skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)

Preferred term

n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(2-)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • -2

formula

  • C77H128N5O45R

mass

  • 1843.850

monoisotopicmass

  • 1842.78813

smiles

  • [C@@]1(O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]3O)O)CO)CO)O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)O[C@@H]5O[C@@H]([C@@H]([C@@H]([C@H]5O)O[C@]6(O[C@]([C@@H]([C@H](C6)O)NC(CO)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O[C@H]7[C@@H]([C@H]([C@@H](O)[C@H](O7)CO)O)NC(C)=O)CO)NC(C)=O)(O[C@]([C@H](NC(=O)C)[C@H](C1)O)([C@@H]([C@H](O)CO)O)[H])C([O-])=O

subset

  • 2_STAR

synonym RELATED

  • beta-D-GalNAc-(1->4)-[alpha-NeuGc-(2->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-NeuAc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d20:1(4E))(2-)
  • GalNAc-GD1a(NeuGc/NeuAc)(d20:1(4E))(2-)
  • ganglioside GalNAc-GD1a(NeuGc/NeuAc) (d20:1(4E))
  • N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyleicosasphing-4E-enine(2-)
  • N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyleicosasphingosine(2-)

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142012

Download this concept:

RDF/XML TURTLE JSON-LD